Regulated Information - Global

Regulated Information

Period

recent search

Showing: 105 of 156 Regulated Information

Share buyback program – Ipsen reporting from 25 July to 29 July 2022 – Detailed
Share buyback program – Ipsen reporting from 25 July to 29 July 2022 – Detailed

This article or press release has no online content. Please download the associated documents for more information.


Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance

Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:


Ipsen publishes its 2022 half year financial report
Ipsen publishes its 2022 half year financial report

This article or press release has no online content. Please download the associated documents for more information.


Share buyback program – Ipsen reporting from 18 July to 22 July 2022 – Detailed
Share buyback program – Ipsen reporting from 18 July to 22 July 2022 – Detailed

This article or press release has no online content. Please download the associated documents for more information.


Share buyback program – Ipsen reporting from 11 July to 15 July 2022 – Detailed
Share buyback program – Ipsen reporting from 11 July to 15 July 2022 – Detailed

This article or press release has no online content. Please download the associated documents for more information.


1 23 24 25 26 27 28 29 32
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.